Longeveron to Participate in Upcoming 2022 Investor Conferences

November 29, 2022

https://www.globenewswire.com/news-release/2022/11/29/2564515/0/en/Longeveron-to-Participate-in-Upcoming-2022-Investor-Conferences.html

MIAMI, Nov. 29, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ:LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced that Company leadership will participate in three upcoming investor conferences.

Read more at globenewswire.com

Related news for (LGVN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.